发明名称 INDAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
摘要 A compound of formula I:;;stereoisomers or a pharmaceutically acceptable salt thereof, wherein X, X1, X2, X3, R1, R2, R3, R4, R5 and R6 are described herein, compositions including the compounds and methods of making and using the compounds for the treatment of diseases.
申请公布号 US2014309210(A1) 申请公布日期 2014.10.16
申请号 US201414178527 申请日期 2014.02.12
申请人 Genentech, Inc. 发明人 Burch Jason;Goldsmith Richard A.;Ortwine Daniel Fred;Pastor Richard;Pei Zhonghua
分类号 C07D403/12;C07D403/14;C07D413/14;C07D491/052;C07D417/14;C07D471/04;C07D409/14;C07D401/14;C07D405/14 主分类号 C07D403/12
代理机构 代理人
主权项 1. A compound of formula I: stereoisomers or a pharmaceutically acceptable salt thereof, wherein: X, X1, X2 and X3 are C or N with the proviso that no more than one of X, X1, X2 and X3 is N; R1, R2, R3 and R4 are independently do not exist, hydrogen, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, halogen, —CN, —OR7, —SR7, —NR7R8, —CF3, —OCF3, —NO2, —C(O)R7, —C(O)OR7, —C(O)NR7R8, —NR7C(O)R8, —S(O)1-2R7, —NR7S(O)1-2R8, —S(O)1-2NR7R8, C3-C6 cycloalkyl, 3-10-membered heterocyclyl or 6-10 membered aryl, wherein R1, R2, R3 and R4 are independently optionally substituted by R9; R5 is does not exist, C1-C6 alkylene, C2-C6 alkenylene, C2-C6 alkynylene, wherein said alkylene, alkenylene and alkynylene are independently optionally substituted by halogen, oxo, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, —OR16, —SR16, —NR16R17, —CN, —C(O)R16, —C(O)OR16, —NR16C(O)R17, —NR16S(O)1-2R17, —CF3, —OCF3, 3-10-membered heterocyclyl or 6-10 membered aryl, and wherein said alkyl, alkenyl, alkynyl, heterocyclyl and phenyl are independently optionally substituted with R9; R6 is hydrogen, C3-C10 cycloalkyl, 3-10-membered heterocyclyl or 6-10-membered aryl, wherein R6 is independently optionally substituted by R9; each R7 and R8 are independently hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, 3-6-membered heterocyclyl or phenyl, wherein said alkyl, cycloalkyl, heterocyclyl and phenyl are independently optionally substituted by halogen, —CN, —CF3, —OCF3, oxo or C1-C6 alkyl optionally substituted by halogen or oxo; or R7 and R8 are independently taken together with the atom to which they are attached to form a 3-6 membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by halogen or oxo; each R9 is independently hydrogen, oxo, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, halogen, —(C0-C6 alkylene)CN, —(C0-C6 alkylene)OR10, —(C0-C6 alkylene)SR10, —(C0-C6 alkylene)NR10R11, —(C0-C6 alkylene)CF3, —(C0-C6 alkylene)NO2, —(C0-C6 alkylene)C(O)R10, —(C0-C6 alkylene)C(O)OR10, —(C0-C6 alkylene)C(O)NR10R11, —(C0-C6 alkylene)NR10C(O)R11, —(C0-C6 alkylene)S(O)1-2R10, —(C0-C6 alkylene)NR10S(O)1-2R11, —(C0-C6 alkylene)S(O)1-2NR10R11, —(C0-C6 alkylene)(C3-C6 cycloalkyl), —(C0-C6 alkylene)(3-10-membered heterocyclyl), —(C0-C6 alkylene)C(O)(3-10-membered heterocyclyl), or —(C0-C6 alkylene)(6-10 membered aryl), wherein each R9 is independently optionally substituted by halogen, oxo, —CF3, —CN, —OR12, —SR12, —NR12R13, —C(O)R12, —S(O)1-2R12, C1-C6 alkyl optionally substituted by oxo or halogen, C2-C6 alkenyl optionally substituted by oxo or halogen, or C2-C6 alkynyl optionally substituted by oxo or halogen; each R10 and R11 are independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, 3-6-membered heterocyclyl, phenyl or C3-C6 cycloalkyl, wherein said alkyl, alkenyl, alkynyl, heterocyclyl, phenyl and cycloalkyl are independently optionally substituted by halogen, oxo, —CF3, —OCF3, —OR14, —SR14, —NR14R15, —CN, 3-6-membered heterocyclyl, phenyl, C3-C6 cycloalkyl or C1-C6 alkyl optionally substituted by halogen or oxo; or R10 and R11 are independently taken together with the atom to which they are attached to form a 3-6 membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by halogen or oxo; each R12 and R13 are independently hydrogen or C1-C6 alkyl optionally substituted by halogen or oxo; or R12 and R13 are independently taken together with the atom to which they are attached to form a 3-6 membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by halogen; each R14 and R15 are independently hydrogen or C1-C6 alkyl optionally substituted by halogen or oxo; or R14 and R15 are independently taken together with the atom to which they are attached to form a 3-6 membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by halogen; each R16 and R17 are independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, 3-6-membered heterocyclyl, phenyl or C3-C6 cycloalkyl, wherein said alkyl, alkenyl, alkynyl, heterocyclyl, phenyl and cycloalkyl are independently optionally substituted by halogen, oxo, —CF3, —OCF3, —OR18, —SR18, —NR18R19, —CN, 3-6-membered heterocyclyl, phenyl, C3-C6 cycloalkyl or C1-C6 alkyl optionally substituted by halogen, —OR20, —NR20R21, or oxo; or R16 and R17 are independently taken together with the atom to which they are attached to form a 3-6 membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by halogen or oxo; each R18 and R19 are independently hydrogen or C1-C6 alkyl optionally substituted by halogen or oxo; or R18 and R19 are independently taken together with the atom to which they are attached to form a 3-6 membered heterocyclyl optionally substituted by halogen, oxo or C1-C6 alkyl optionally substituted by halogen; and each R20 and R21 are independently hydrogen or C1-C6 alkyl optionally substituted by halogen or oxo; other than N-(1-ethyl-1H-pyrazol-4-yl)-1H-indazole-3-carboxamide; 5-amino-N-(1-ethyl-1H-pyrazol-4-yl)-1H-indazole-3-carboxamide; 5-amino-N-(1-methyl-1H-pyrazol-4-yl)-1H-Indazole-3-carboxamide; N-[1-(imidazo[1,2-a]pyridin-2-ylmethyl)-1H-pyrazol-4-yl]-1H-Indazole-3-carboxamide; N-[1-[2-(diethylamino)ethyl]-1H-pyrazol-4-yl]-1H-Indazole-3-carboxamide; N-(1-methyl-1H-pyrazol-4-yl)-5-nitro-1H-Indazole-3-carboxamide; N-[1-[2-(3,4-dimethoxyphenyl)ethyl]-1H-pyrazol-4-yl]-1H-Indazole-3-carboxamide; 4-[(2H-indazol-3-ylcarbonyl)amino]-1H-Pyrazole-1-acetic acid; N-[1-[2-(phenylmethoxy)ethyl]-1H-pyrazol-4-yl]-1H-Indazole-3-carboxamide; N-[1-(4-cyanobutyl)-1H-pyrazol-4-yl]-1H-Indazole-3-carboxamide; or N-[1-[(3-cyanophenyl)methyl]-1H-pyrazol-4-yl]-1H-Indazole-3-carboxamide.
地址 South San Francisco CA US